Q: Savaria missed on revs and EPS so it is weak on the open. Things seem to be moving in the right direction; org growth in North America Accessibility up 12%, Patient care also strong growth. Does this look like a company ready to accelerate profits in the next 12 months?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Constellation Software Inc. (CSU)
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP)
-
goeasy Ltd. (GSY)
-
Topicus.com Inc. (TOI)
Q: Hello team, I have room for a full position in my TFSA. Goal is long term growth. Out of CSU, GSY, SHOP, and TOI what company(s) has the best chance of long term growth over the next 5 years, and are todays prices OK entries?
Thanks again,
Derek.
Thanks again,
Derek.
Q: I know you hold this company in the Model Growth Portfolio. I have a small holding and it is down around 70%. My plan was to continue to hold and hope it improves as the macroenvironment improves. With the stock price so low now, I hope it has hit bottom. On the other hand, I do need some losses this year to offset gains. I assume by tendering my shares via the auction, I can avoid any broker fees? What are your thoughts on continuing to hold versus tendering shares via their auction?
Thanks.
Thanks.
Q: Long time holder of KXS. They reported recently. Just your thoughts on results and future. Thanks.
Robert
Robert
Q: Your analysis of results and outlook, please
Sheldon
Sheldon
Q: What does the market expect from CSU this quarter?
Thx
Thx
Q: What is expected for gsy, kxs and sis tonight?
Q: Is PBH add/hold or sell today? Breaking even today in a small TFSA after a long hold.
Q: Hello,
I would appreciate your thoughts on how the arrival of new diabetes/weight loss drugs (Ozempic, Wegovy and Mounjaro) might potentially impact the future revenues at Body Contour Centers? Could the advent of these new medications not have a significant potential impact on the existing players in the weight loss space?
Are you able to provide an estimate of what proportion of Alaris Equity Partners' existing annual income is attributable to their investment in Body Contour Centers?
Thank you!
I would appreciate your thoughts on how the arrival of new diabetes/weight loss drugs (Ozempic, Wegovy and Mounjaro) might potentially impact the future revenues at Body Contour Centers? Could the advent of these new medications not have a significant potential impact on the existing players in the weight loss space?
Are you able to provide an estimate of what proportion of Alaris Equity Partners' existing annual income is attributable to their investment in Body Contour Centers?
Thank you!
Q: Can you provide your opinion on the most recent earnings report? Thanks
Q: Would you trade CAE for TIH?
Q: I have owned CAE for a few years now, and it's been kind of a dog to say the least. What did you think of their earnings?
Q: Can you comment on earnings release and current valuation.
Q: Please comment on CTS earnings release. Is this stock still a hold?
Q: WSP global recently reported earnings. Your thoughts on their recent quarter. Thanks.
Robert
Robert
Q: Hi Team,
Can I have your thoughts on nvei earnings? Currently the market is not happy with them and SP is dropping like a stone. In the release I see the net earnings have collapsed due to what appears to be interest payments on debt. This being said; what would possess them to start giving out a cash dividend when net income is almost now zero? Wouldn't the money be better spent trying to pay the debt down that is now sinking their net earnings? It seems even though revenue is building and even though they keep adding new customers they just can't get their earnings to improve. Is it time to dump this name or hold out for better days, or perhaps a takeout?
Shane.
Can I have your thoughts on nvei earnings? Currently the market is not happy with them and SP is dropping like a stone. In the release I see the net earnings have collapsed due to what appears to be interest payments on debt. This being said; what would possess them to start giving out a cash dividend when net income is almost now zero? Wouldn't the money be better spent trying to pay the debt down that is now sinking their net earnings? It seems even though revenue is building and even though they keep adding new customers they just can't get their earnings to improve. Is it time to dump this name or hold out for better days, or perhaps a takeout?
Shane.
Q: Based on the recent earnings report it looks like Nuvei's growth is challenged. The announcement of a modest dividend appears to be an effort to mollify negative sentiment. Given the recent negative momentum and the muted forward guidance, please give your opinion on continuing to hold at a considerable loss (TFSA) vs selling and redeploying the cash to add to either TRI or ATS. Thank you. Please use as many credits as you need.
Q: Today, in reply to a question you wrote :Given the appropriate valuation, we would be comfortable holding ENB for dividend growth.
Do you think there is a reasonable possibility for share price appreciation as well? If so , what would be the reason: a flight to safety? Drop in interest rates? How well does it do in a recessionary environment?
Do you think there is a reasonable possibility for share price appreciation as well? If so , what would be the reason: a flight to safety? Drop in interest rates? How well does it do in a recessionary environment?
Q: WSP sold Berger Services yesterday. Is this material? Why was it sold?
Q: I'm curious about your support for Atco. Is it because it's inexpensive or is there something else going on here?